Ann Hynes
Stock Analyst at Mizuho
(5.00)
# 2
Out of 4,859 analysts
250
Total ratings
65%
Success rate
187.02%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $515 → $350 | $318.50 | +9.89% | 18 | May 16, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $200 → $173 | $147.09 | +17.62% | 15 | May 15, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $210 → $190 | $159.13 | +19.40% | 12 | May 15, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $37 → $32 | $22.14 | +44.53% | 11 | May 14, 2025 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $10 → $8 | $6.29 | +27.19% | 3 | May 14, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $178 → $189 | $178.77 | +5.73% | 14 | Apr 9, 2025 | |
| MOH Molina Healthcare | Maintains: Outperform | $376 → $400 | $293.13 | +36.46% | 8 | Apr 9, 2025 | |
| MEDP Medpace Holdings | Maintains: Outperform | $400 → $355 | $304.11 | +16.74% | 2 | Apr 9, 2025 | |
| HUM Humana | Maintains: Outperform | $305 → $316 | $234.96 | +34.49% | 8 | Apr 9, 2025 | |
| ELV Elevance Health | Maintains: Outperform | $455 → $505 | $385.93 | +30.85% | 4 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $155 | $152.04 | +1.95% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $76 | $66.36 | +14.53% | 10 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $18 | $13.51 | +33.23% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $14.25 | +5.30% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $160.43 | -25.20% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $21.58 | -7.32% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $21.76 | +28.68% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $118 → $130 | $165.55 | -21.47% | 14 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $120.18 | -20.95% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $314.99 | +22.23% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $173.66 | +15.17% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.83 | +14,584.93% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $730.32 | -30.85% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $261.72 | -12.12% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $371.55 | -25.99% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $25 | $11.36 | +120.07% | 8 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $23.09 | +116.59% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $76 | $55.35 | +37.31% | 7 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.52 | +3,651.73% | 1 | Sep 21, 2017 |
UnitedHealth Group
May 16, 2025
Maintains: Outperform
Price Target: $515 → $350
Current: $318.50
Upside: +9.89%
ICON Public Limited Company
May 15, 2025
Maintains: Outperform
Price Target: $200 → $173
Current: $147.09
Upside: +17.62%
IQVIA Holdings
May 15, 2025
Maintains: Outperform
Price Target: $210 → $190
Current: $159.13
Upside: +19.40%
Acadia Healthcare Company
May 14, 2025
Maintains: Neutral
Price Target: $37 → $32
Current: $22.14
Upside: +44.53%
Fortrea Holdings
May 14, 2025
Maintains: Neutral
Price Target: $10 → $8
Current: $6.29
Upside: +27.19%
Quest Diagnostics
Apr 9, 2025
Maintains: Outperform
Price Target: $178 → $189
Current: $178.77
Upside: +5.73%
Molina Healthcare
Apr 9, 2025
Maintains: Outperform
Price Target: $376 → $400
Current: $293.13
Upside: +36.46%
Medpace Holdings
Apr 9, 2025
Maintains: Outperform
Price Target: $400 → $355
Current: $304.11
Upside: +16.74%
Humana
Apr 9, 2025
Maintains: Outperform
Price Target: $305 → $316
Current: $234.96
Upside: +34.49%
Elevance Health
Apr 9, 2025
Maintains: Outperform
Price Target: $455 → $505
Current: $385.93
Upside: +30.85%
Apr 9, 2025
Maintains: Neutral
Price Target: $175 → $155
Current: $152.04
Upside: +1.95%
Apr 9, 2025
Maintains: Outperform
Price Target: $70 → $76
Current: $66.36
Upside: +14.53%
Apr 9, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $13.51
Upside: +33.23%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $14.25
Upside: +5.30%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $160.43
Upside: -25.20%
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $21.58
Upside: -7.32%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $21.76
Upside: +28.68%
May 1, 2024
Reiterates: Buy
Price Target: $118 → $130
Current: $165.55
Upside: -21.47%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $120.18
Upside: -20.95%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $314.99
Upside: +22.23%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $173.66
Upside: +15.17%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.83
Upside: +14,584.93%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $730.32
Upside: -30.85%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $261.72
Upside: -12.12%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $371.55
Upside: -25.99%
Oct 10, 2023
Maintains: Neutral
Price Target: $31 → $25
Current: $11.36
Upside: +120.07%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $23.09
Upside: +116.59%
Jul 11, 2023
Maintains: Neutral
Price Target: $80 → $76
Current: $55.35
Upside: +37.31%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.52
Upside: +3,651.73%